This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a pharmacokinetic study to examine the plasma kinetics of the combination of Lopinavir/ Ritonavir (LPVr) as a single dose 800/200. This study will include 40 subjects, 10 for each gender and ethnic classification, who have demonstrated a tolerance for LPVr 400/100 during a 14-day phase-in period.
Showing the most recent 10 out of 675 publications